Tela Bio
TELA59
$3.09arrow_drop_up1.98%$0.06
Penny Stock
TELA59
$3.09
arrow_drop_up1.98%Performance History
| Key Stats | |
|---|---|
| Open | $3.05 |
| Prev. Close | $3.03 |
| EPS | -1.69 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $120.13M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 3.02 | 3.11 |
| 52 Week Range | 2.32 | 7.84 |
| Ratios | |
|---|---|
| EPS | -1.69 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Tela Bio (TELA)
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Antony Koblish
- Headquarters
- Malvern
- Employees
- 173
- Exchange
- NASDAQ
Keep an eye on Tela Bio
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Tela Bio 's (TELA) price per share?
The current price per share for Tela Bio (TELA) is $3.09. The stock has seen a price change of $0.06 recently, indicating a 1.98% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Tela Bio (TELA)?
For Tela Bio (TELA), the 52-week high is $7.84, which is 153.72% from the current price. The 52-week low is $2.32, the current price is 33.19% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Tela Bio (TELA) a growth stock?
Tela Bio (TELA) has shown an average price growth of -3.72% over the past three years. It has received a score of 10 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Tela Bio as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Tela Bio (TELA) stock price performance year to date (YTD)?
As of the latest data, Tela Bio (TELA) has a year-to-date price change of -53.32%. Over the past month, the stock has experienced a price change of 8.42%. Over the last three months, the change has been 3%. Over the past six months, the figure is -46.17%. Looking at a longer horizon, the five-year price change stands at -72.87%.
help
Is Tela Bio (TELA) a profitable company?
Tela Bio (TELA) has a net income of -$46.66M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.62% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -49.4% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $58.45M, with a revenue growth rate of 41.13%, providing insight into the company's sales performance and growth. The gross profit is $40.11M. Operating income is noted at -$44.08M. Furthermore, the EBITDA is -$44.71M.
help
What is the market capitalization of Tela Bio (TELA)?
Tela Bio (TELA) has a market capitalization of $120.13M. The average daily trading volume is 3.08, indicating the stock's liquidity and investor engagement.
News
TELA BIO
PUBLIC OFFERING
COMMON STOCK
PRE-FUNDED WARRANTS
PROCEEDS
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares
DIRECTORS AND OFFICERS
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
DIRECTORS AND OFFICERS
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
CHANGES IN COMPANY'S OWN SHARES
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 6, 2024
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Top Estimates
May 2, 2024
The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates